textabstractDespite the favorable impact of drug eluting stents on stent restenosis, their long-term reliability is considered worrisome by some because of stent thrombosis. Often attributed to adverse reactions to the stent platform, both the drugs and polymer characteristics have been further advanced with current technologies. The present review discussed current drug eluting stents and new developments
First-generation drug-eluting stents (DES) with controlled release of sirolimus or paclitaxel from d...
Despite all the benefits of drug-eluting stents (DES), concerns have been raised over their long-ter...
Introduction: Percutaneous coronary intervention is a widely used procedure for the treatment of cor...
Despite the favorable impact of drug eluting stents on stent restenosis, their long-term reliability...
This review aims to provide a glimpse into the future of drug-eluting stents (DES). Since their arri...
Currently, more than 4 million patients receive drug-eluting stents worldwide. Despite recent studie...
The introduction of drug-eluting stents (DES) has rapidly and profoundly affected the field of inter...
Thein Htay, Ming W LiuDivision of Cardiovascular Medicine, Department of Medicine, Keck School of Me...
Drug-eluting stents (DESs) have been prevailing for the treatment of CAD in the interventional cardi...
The introduction of drug eluting stents has resulted in dramatic reductions in the rates of restenos...
© 2014 Bentham Science Publishers.The interventional treatment of coronary artery disease was introd...
The arrival of drug-eluting stents (DES) nearly 2 decades ago ignited a revolution in the field of i...
AbstractPercutaneous coronary intervention is currently the most common revascularization procedure ...
Despite the success of drug-eluting stents (DES) in reducing restenosis and the need for target vess...
Although first-generation drug-eluting stents (DES) have significantly reduced the risk of in-stent ...
First-generation drug-eluting stents (DES) with controlled release of sirolimus or paclitaxel from d...
Despite all the benefits of drug-eluting stents (DES), concerns have been raised over their long-ter...
Introduction: Percutaneous coronary intervention is a widely used procedure for the treatment of cor...
Despite the favorable impact of drug eluting stents on stent restenosis, their long-term reliability...
This review aims to provide a glimpse into the future of drug-eluting stents (DES). Since their arri...
Currently, more than 4 million patients receive drug-eluting stents worldwide. Despite recent studie...
The introduction of drug-eluting stents (DES) has rapidly and profoundly affected the field of inter...
Thein Htay, Ming W LiuDivision of Cardiovascular Medicine, Department of Medicine, Keck School of Me...
Drug-eluting stents (DESs) have been prevailing for the treatment of CAD in the interventional cardi...
The introduction of drug eluting stents has resulted in dramatic reductions in the rates of restenos...
© 2014 Bentham Science Publishers.The interventional treatment of coronary artery disease was introd...
The arrival of drug-eluting stents (DES) nearly 2 decades ago ignited a revolution in the field of i...
AbstractPercutaneous coronary intervention is currently the most common revascularization procedure ...
Despite the success of drug-eluting stents (DES) in reducing restenosis and the need for target vess...
Although first-generation drug-eluting stents (DES) have significantly reduced the risk of in-stent ...
First-generation drug-eluting stents (DES) with controlled release of sirolimus or paclitaxel from d...
Despite all the benefits of drug-eluting stents (DES), concerns have been raised over their long-ter...
Introduction: Percutaneous coronary intervention is a widely used procedure for the treatment of cor...